Feb 19, 2026 08:39AM
Feb 19, 2026 08:39AM
Feb 18, 2026 08:20AM
Feb 18, 2026 08:20AM
Feb 17, 2026 08:35AM
Feb 17, 2026 08:35AM
Feb 13, 2026 08:35AM Moleculin launches CEO Corner platform for investor communication
Feb 13, 2026 08:32AM
Feb 5, 2026 09:15AM
Jan 13, 2026 08:55AM
Jan 13, 2026 08:55AM
Jan 12, 2026 08:37AM
Jan 12, 2026 08:36AM
Dec 17, 2025 08:31AM Moleculin reports positive Phase 1 results for pediatric brain tumor drug
Dec 17, 2025 08:31AM
Dec 10, 2025 08:30AM
Dec 10, 2025 08:30AM
Dec 9, 2025 08:07AM
Dec 9, 2025 08:07AM
Dec 8, 2025 08:21AM
Dec 8, 2025 08:21AM Moleculin Announces New Annamycin Collaboration in Brain Tumors
Nov 26, 2025 09:15AM
Nov 26, 2025 09:00AM
Nov 26, 2025 09:00AM
Nov 13, 2025 08:36AM
Nov 13, 2025 08:36AM
Nov 12, 2025 08:37AM
Oct 30, 2025 08:40AM Moleculin to present Phase 3 leukemia trial at Madrid conference
Oct 30, 2025 08:40AM
Oct 29, 2025 08:35AM
Oct 29, 2025 08:35AM
Oct 23, 2025 08:00AM
Sep 25, 2025 08:35AM
Sep 25, 2025 08:35AM
Sep 9, 2025 08:45AM Moleculin expands MIRACLE trial recruitment across Europe and US
Sep 9, 2025 08:45AM
Sep 8, 2025 08:30AM
Sep 8, 2025 08:30AM
Aug 28, 2025 08:30AM
Aug 27, 2025 08:45AM
Aug 14, 2025 09:15AM
Aug 13, 2025 08:05AM Moleculin Reports Second Quarter 2025 Financial Results and Highlights
Aug 6, 2025 08:42AM
Aug 6, 2025 08:40AM
Jul 30, 2025 08:35AM
Jul 30, 2025 08:35AM
Jul 22, 2025 08:45AM
Jul 17, 2025 08:25AM
Jul 17, 2025 08:25AM Moleculin Engages Industry Veteran Adriano Treve to Explore Accelerated Strategic Partnerships
Jul 9, 2025 08:37AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All